4. THE EFFICACY OF SECOND-LINE TREATMENT WITH DOCETAXEL FOR PATIENTS WITH NON-SMALL CELL LUNG CANCER STAGE IIIB-IV AT E HOSPITAL. YHCĐ. 2022;64(1). doi:10.52163/yhc.v64i1.567